UBS Group »

Xtl Biopharmaceuticals Ltd sponsored adr ne shares owned by UBS Group

Quarter-by-quarter ownership of Xtl Biopharmaceuticals Ltd sponsored adr ne (XTLB) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Xtl Biopharmaceuticals Ltd sponsored adr ne

Tip: Access up to 7 years of quarterly data

All positions including Xtl Biopharmaceuticals Ltd sponsored adr ne held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xtl Biopharmaceuticals Ltd sponsored adr ne by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $893 763 1.17
2025-06-30 $1.5k 1.3k 1.14
2024-03-31 $20k 7.0k 2.81
2023-12-31 $54 54 1.02
2023-09-30 $108 120 0.90
2022-12-31 $363 300 1.21
2022-03-31 $2.0k 812 2.46
2021-12-31 $0 154 0.00
2021-09-30 $13k 2.9k 4.49
2021-03-31 $12k 3.5k 3.41
2020-09-30 $2.0k 1.0k 1.93
2019-12-31 $2.0k 1.2k 1.63
2019-09-30 $5.0k 3.3k 1.50
2019-06-30 $7.0k 3.5k 1.98
2019-03-31 $15k 6.3k 2.37
2018-12-31 $12k 6.7k 1.80
2018-09-30 $0 6.5k 0.00
2018-06-30 $1.0k 692 1.45
2018-03-31 $2.0k 1.1k 1.77
2017-12-31 $2.0k 703 2.84
2017-09-30 $7.0k 3.0k 2.30
2017-06-30 $52k 16k 3.19
2017-03-31 $14k 5.3k 2.63

Top funds holding Xtl Biopharmaceuticals Ltd sponsored adr ne